Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical Performance
出版年份 2012 全文链接
标题
Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical Performance
作者
关键词
-
出版物
Annual Review of Pharmacology and Toxicology
Volume 53, Issue 1, Pages 161-185
出版商
Annual Reviews
发表日期
2012-10-09
DOI
10.1146/annurev-pharmtox-011112-140341
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
- (2012) R. C. Doebele et al. ANNALS OF ONCOLOGY
- JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths
- (2012) A. Tefferi BLOOD
- c-Met upregulates aquaporin 3 expression in human gastric carcinoma cells via the ERK signalling pathway
- (2012) Jianping Wang et al. CANCER LETTERS
- Met Kinase Inhibitor E7050 Reverses Three Different Mechanisms of Hepatocyte Growth Factor-Induced Tyrosine Kinase Inhibitor Resistance in EGFR Mutant Lung Cancer
- (2012) W. Wang et al. CLINICAL CANCER RESEARCH
- A Phase I Trial of Erlotinib and Concurrent Chemoradiotherapy for Stage III and IV (M0) Squamous Cell Carcinoma of the Head and Neck
- (2012) J. Gilbert et al. CLINICAL CANCER RESEARCH
- Mechanisms of Resistance to Crizotinib in Patients withALKGene Rearranged Non–Small Cell Lung Cancer
- (2012) Robert C. Doebele et al. CLINICAL CANCER RESEARCH
- Oncogene addiction
- (2012) Jeffrey Settleman CURRENT BIOLOGY
- Treatment of nonsmall cell lung cancer
- (2012) Corey A. Carter et al. CURRENT OPINION IN ONCOLOGY
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Biophysical and Mechanistic Insights into Novel Allosteric Inhibitor of Spleen Tyrosine Kinase
- (2012) Justin Hall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Imatinib Sensitizes T-cell Lymphocytes From Chronic Myeloid Leukemia Patients to FasL-induced Cell Death
- (2012) Laurence Legros et al. JOURNAL OF IMMUNOTHERAPY
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis
- (2011) E. Bria et al. ANNALS OF ONCOLOGY
- Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs
- (2011) Roy Fleischmann et al. ARTHRITIS AND RHEUMATISM
- The many faces of Janus kinase
- (2011) Matthew M. Seavey et al. BIOCHEMICAL PHARMACOLOGY
- Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy
- (2011) Satoru Takahashi BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Dual HER2-targeted approaches in HER2-positive breast cancer
- (2011) Eugene R. Ahn et al. BREAST CANCER RESEARCH AND TREATMENT
- p95HER2 and Breast Cancer
- (2011) J. Arribas et al. CANCER RESEARCH
- Treatment with Interferon alpha prior to discontinuation of Imatinib in patients with chronic myeloid leukemia
- (2011) Izhar Hardan et al. CYTOKINE
- Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistance
- (2011) Rebekka Krumbach et al. EUROPEAN JOURNAL OF CANCER
- EGFR-targeted therapy
- (2011) Loredana Vecchione et al. EXPERIMENTAL CELL RESEARCH
- Antiangiogenic treatments and mechanisms of action in renal cell carcinoma
- (2011) Sylvie Négrier et al. INVESTIGATIONAL NEW DRUGS
- Imatinib Mesylate-Incorporated Nanoparticle-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary Arteries
- (2011) Seigo Masuda et al. Journal of Atherosclerosis and Thrombosis
- Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer
- (2011) Takayuki Kosaka et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
- (2011) Masahiro Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer
- (2011) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Conversion from the “oncogene addiction” to “drug addiction” by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation
- (2011) Kenichi Suda et al. LUNG CANCER
- Vandetanib—a new therapeutic option in advanced medullary thyroid cancer
- (2011) Linda Koch Nature Reviews Endocrinology
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study
- (2011) Maria J Overbeek et al. ARTHRITIS RESEARCH & THERAPY
- Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
- (2011) Hari Deshpande et al. OncoTargets and Therapy
- Increased Expression of Angiopoietins and Tie2 in the Lungs of Chronic Asthmatic Mice
- (2010) Toluwalope O. Makinde et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma
- (2010) Babita Saigal et al. ANTI-CANCER DRUGS
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Allosteric inhibition of BCR-ABL
- (2010) A. Quamrul Hassan et al. CELL CYCLE
- The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations
- (2010) B. Comin-Anduix et al. CLINICAL CANCER RESEARCH
- Pazopanib: Clinical development of a potent anti-angiogenic drug
- (2010) Fabio A.B. Schutz et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia
- (2010) Andreas Burchert et al. JOURNAL OF CLINICAL ONCOLOGY
- Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoattractant-Induced Signaling via the Ras-ERK and PI3K-Akt Networks, along with Leukotriene C4 Release, Is Dependent on the Tyrosine Kinase Lyn in IL-5- and IL-3-Primed Human Blood Eosinophils
- (2010) Y. Zhu et al. JOURNAL OF IMMUNOLOGY
- Signal transduction therapy of cancer
- (2010) Alexander Levitzki et al. MOLECULAR ASPECTS OF MEDICINE
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
- (2010) Masayuki Nitta et al. PLoS One
- Imatinib Treatment for Idiopathic Pulmonary Fibrosis
- (2009) Craig E. Daniels et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhibition of Pyk2 Blocks Airway Inflammation and Hyperresponsiveness in a Mouse Model of Asthma
- (2009) Yingli Duan et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Targeting the EGFR and the PKB pathway in cancer
- (2009) Shoshana Klein et al. CURRENT OPINION IN CELL BIOLOGY
- Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia
- (2009) J. M. A. Daniels et al. EUROPEAN RESPIRATORY JOURNAL
- Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis
- (2009) Mary G. Boy et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pharmacology of airway smooth muscle proliferation
- (2008) Reinoud Gosens et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started